3 patents
Utility
Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells
23 Nov 21
Provided herein are methods of treating acute myeloid leukemia (AML) and multiple myeloma (MM) by administering an effective amount of a cell population comprising natural killer cells, wherein the cell population comprising natural killer cells is produced by a three-stage method comprising culturing a population of hematopoietic stem or progenitor cells in media comprising stem cell mobilizing factors, e.g., three-stage methods of producing NK cells in media comprising stem cell mobilizing factors starting with hematopoietic stem or progenitor cells from cells of the placenta, for example, from placental perfusate (e.g., human placental perfusate) or other tissues, for example, umbilical cord blood or peripheral blood.
Steven A. Fischkoff, Uri Herzberg, Lin Kang, Brian Murphy, Andrea Nordberg, Vanessa Voskinarian-Berse, Keith Wilson, Xiaokui Zhang, Han Myint, Mohamad Hussein, Robert J Hariri
Filed: 5 May 17
Utility
Placenta-derived adherent cell exosomes and uses thereof
16 Nov 21
Provided herein are compositions of placenta-derived adherent cell exosomes and methods of making and using the same.
Eric Law, Andrew Morschauser, Aleksander Francki, Jennifer Paredes, Kathy Karasiewicz-Mendez, Allan Reduta, Vladimir Jankovic, Ivana Djuretic, Robert J. Hariri
Filed: 10 Jan 20
Utility
Treatment of pain using placental stem cells
17 Aug 21
Provided herein are methods of treatment of an individual having pain, e.g., neuropathic pain, comprising administering to the individual a therapeutically effective amount of tissue culture plastic adherent placental stem cells (PDAC™).
Uri Herzberg, Jodi P. Gurney, Robert J. Hariri
Filed: 5 Aug 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first